Interagency Patent Coordination and Improvement Act of 2023

Hozzl · 2024-02-14T19:25:08Z

Explore the details of Senate Bill 79 Interagency Patent Coordination and Improvement Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Commerce. Stay informed on legislative developments.

2/14/2024, 7:25 PM

Congressional Summary of S 79

Interagency Patent Coordination and Improvement Act of 2023

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the PTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the PTO, and (3) the PTO to assist the FDA in its ministerial role of listing patents.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 79

Bill S 79 is currently in the status of Bill Introduced since January 25, 2023. Bill S 79 was introduced during Congress 118 and was introduced to the Senate on January 25, 2023. Bill S 79's most recent activity was Placed on Senate Legislative Calendar under General Orders. Calendar No. 18. as of March 1, 2023

Bipartisan Support of Bill S 79

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 79

Primary Policy Focus

Commerce

Potential Impact Areas

- Administrative remedies

- Department of Commerce

- Drug safety, medical device, and laboratory regulation

- Food and Drug Administration (FDA)

- Intellectual property

- Intergovernmental relations

Alternate Title(s) of Bill S 79

Interagency Patent Coordination and Improvement Act of 2023

A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.